ClinicalTrials.Veeva

Menu

Development of Human Laboratory Study Model of Cocaine Relapse Prevention. - 1

National Institutes of Health (NIH) logo

National Institutes of Health (NIH)

Status and phase

Unknown
Phase 1

Conditions

Cocaine-Related Disorders

Treatments

Procedure: Cocaine (IV)

Study type

Interventional

Funder types

NIH

Identifiers

NCT00040066
NIDA-CTO-0013-1

Details and patient eligibility

About

The purpose of this study is to assess the development of human laboratory study model of cocaine relapse prevention.

Full description

The primary objective of this study will be to develop experimental procedures and parameters demonstrating arousal and craving responses to cocaine-related environmental cues as a model for future testing of the relapse prevention medication treatment of cocaine addiction.

Sex

All

Ages

18 to 55 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Cocaine dependent, non treatment seeking individuals

Exclusion criteria

Please contact site directly for details.

Trial contacts and locations

2

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems